Venmax Drugs and Pharmaceuticals Ltd has announced a board meeting on a tribunal directive to convene and hold a meeting of its equity shareholders regarding the scheme of amalgamation involving the company.

This shareholder meeting is a key step in advancing the amalgamation process, directly impacting the corporate structure and governance of the firm.

Shareholders need to vote on this strategic restructuring proposal as it progresses through the judicial and regulatory framework.